InnovAge Holding Corp. Common Stock (INNV) Stock Price
INNVStock
$8.85+60.91%52W
Market Cap$1.21B
P/E—
PEG Ratio—
Div yield—
Beta0.16
INNV Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-1.58%
Price vs S&P 500 (4W)-15.18%
VGM Score46.54
INNV Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.08 | $0.10 | +29.25%(+$0.02) | |
| Q1 2026 | $0.05 | $0.17 | +246.40%(+$0.12) | |
| Q4 2025 | $0.04 | $0.10 | +144.00%(+$0.06) | |
| Q3 2025 | $0.04 | $0.07 | +74.50%(+$0.03) | |
| Q2 2025 | $0.01 | $0.07 | +596.00%(+$0.06) |
INNV Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
2.33
2.33
2.33
2.44
Industry Peers — Health Services(21)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
INNVInnovAge Holding Corp. Common Stock | D | C | C | — | 15.9% | 0.3% | -1.1% | $8.85 |
| LFSTLifeStance Health Group, Inc. Common Stock | D | A | B | 464.3x | 61.1% | 4.9% | 3.4% | $11.74 |
| PRVAPrivia Health Group, Inc. Common Stock | C | B | C | 125.5x | 24.1% | 1.9% | 3.8% | $22.52 |
| WGSGeneDx Holdings Corp. Class A Common Stock | F | B | D | — | 25.4% | -21.8% | -38.7% | $63.61 |
| PNTGThe Pennant Group, Inc. Common Stock | D | B | B | 49.4x | 37.9% | 5.7% | 9.5% | $41.87 |
| USPHUS Physical Therapy Inc | C | D | C | 32.3x | 11.3% | 9.4% | 6.8% | $85.71 |
| OMDAOmada Health, Inc. Common Stock | D | B | D | — | 8.3% | -0.8% | 1.8% | $17.63 |
| PIIIP3 Health Partners Inc. Common Stock | A | C | D | — | 2.8% | -9.9% | 10.3% | $4.14 |
| SRTAStrata Critical Medical, Inc. Class A Common Stock | B | B | C | 9.7x | 18.8% | -8.0% | 14.3% | $4.54 |
| ALPSALPS Group Inc Ordinary Share | — | — | D | — | — | — | — | $0.34 |
| EUDAEUDA Health Holdings Limited Ordinary Shares | C | B | C | — | 66.9% | -36.5% | -1.8% | $15.40 |
About InnovAge Holding Corp. Common Stock
InnovAge operates a capitated healthcare platform serving high-cost seniors, including dual-eligible beneficiaries, through its PACE (Program of All-Inclusive Care for the Elderly) model. The company's participant-centered approach delivers integrated care while keeping seniors independent at home, reducing costly hospital and nursing home admissions. This model addresses rising U.S. healthcare costs while improving care quality and outcomes.